Journals / Retina-Vitreus / 2013 / Cilt: 21 - Sayı: 3

Why proliferative vitreoretinopathy occurs?

Proliferatif vitreoretinopati neden oluşur?

Pages
155–159
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The purpose of this review is to summarize contemporary findings relevant to the pathophysiology of PVR.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Proliferative vitreoretinopathy (PVR) is still a major cause of failure of retinal detachment surgery.
📊
Key Findings & Data:Despite a dramatic increase in our pathobiologic knowledge of PVR during the last 10 years, little of this information has been used to modify the surgical management of the PVR.
💡
Conclusion & Impact:The purpose of this review is to summarize contemporary findings relevant to the pathophysiology of PVR.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Proliferative vitreoretinopathy (PVR) is still a major cause of failure of retinal detachment surgery. Despite a dramatic increase in our pathobiologic knowledge of PVR during the last 10 years, little of this information has been used to modify the surgical management of the PVR. The cell biology and molecular mediators of proliferative vitreoretinopathy continue to be elucidated. The purpose of this review is to summarize contemporary findings relevant to the pathophysiology of PVR.

Özet

Proliferatif vitreoretinopati (PVR), halen retina dekolman cerrahisindeki başarısızlığın en önemli nedenidir. Son yıllar- da PVR’nin patobiyolojisini anlama yönündeki bilgilerimiz belirgin olarak artmış olsa da, bu bilginin çok az bir bölümü PVR’nin cerrahi tedavisini düzenleme konusunda kullanılabilmiştir. PVR’nin hücre biyolojisi ve moleküler mediyatörleri halen incelenmeye devam etmektedir. Bu derlemenin amacı PVR’nin fizyopatolojisi hakkında güncel bilgileri özetlemektir.

🔖

Cite This Article

DURUKAN, A. H. (2013). Why proliferative vitreoretinopathy occurs?. Retina-Vitreus, Cilt: 21 - Sayı: 3, 155–159. https://ajindex.com/articles/305077

References (18)

  1. The SPR Study Group. View 2: The case for primary vitrec- tomy. Br J Ophthalmol 2003;87:784-7
  2. Pastor JC: Proliferative vitreoretinopathy: an overview. Surv Ophthalmol 1998; 43: 3-18
  3. The Retina Society Terminology Committee. The classifica- tion of retinal detachment with proliferative vitreoretinopa- thy. Ophthalmology 1983;90:121-5
  4. Lean JS, Stern WH, Irvine A, et al. The Silicone Study Group. Classification of proliferative vitreoretinopathy used in the Silicone Study. Ophthalmology 1989;96:756-71
  5. Kita T. Molecular mechanisms of preretinal membrane contraction in proliferative vitreoretinal diseases and ROCK as a therapeutic target. Nihon Ganka Gakkai Zasshi 2010;114:927-34
  6. Charteris DG. Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Oph- thalmol 1995;79:953-60
  7. Ivana KK, Jorge GA. Mechanisms in proliferative vitreoreti- nopathy. Ophthalmol Clin N Am 2002;15:81-8
  8. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738-46
  9. Mietz H, Heimann K. Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal diseases. Br J Oph- thalmol 1995;79:874-7
  10. Girard P, Mimoun G, Karpouzas I, et al. Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery. Retina 1994;14:417-24
  11. Nagasaki H, Shinagawa K, Mochizuki M. Risk factors for pro- liferative vitreoretinopathy. Prog Retin Eye Res 1998;17:77-98
  12. Kon CH, Asaria RH, Occeleston NL, et al. Risk factors for pro- liferative vitreoretinopathy after primary vitrectomy: a pro- spective study. Br J Ophthalmol 2000;84:506-11
  13. Miura M, Ideta H. Factors related to subretinal proliferation in patients with primary rhegmatogenous retinal detach- ment. Retina 2000;20:465-8
  14. Pastor JC, Rua R, Martin F. Proliferative vitreoretinopa- thy: risk factors and pathobiology. Prog Retin Eye Res 2002; 21:127-44
  15. Baudouin C, Hofman P, Brignole F, et al. Immunocytology of cellular components in vitreous and subretinal fluid from pa- tients with proliferative vitreoretinopathy. Ophthalmologica 1991;203:38-46
  16. Sramek S, Wallow Y, Stevens T, et al. Immunostaining of pre- retinal membranes for actin, fibronectin, and glial fibrillary acidic protein. Ophthalmology 1989;96:835-41
  17. Pournaras CJ, Donati G, Kapetanios AD, et al. Myofibros- blasts and retinal fibrovascular membranes. Klin Monatsbl Augenheilkd 1998;212:356-58
  18. Charteris DG, Hiscott P, Grierson I, et al